March 6, 2024

Upcoming EL-PFDD Meetings

To promote transparency and communication, FDA is sharing a list of disease areas where a letter of intent (LOI) has been submitted and ongoing plans exist […]
March 6, 2024

Outsourcing Facilities Annual Study

The FDA Compounding Quality Center of Excellence conducts the Compounding Outsourcing Facilities Annual Study to better understand industry perspectives and challenges, as well as dynamics between […]
March 6, 2024

Q14 Analytical Procedure Development

Docket Number: FDA-2022-D-1503 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research, Office of Regulatory Policy Center for Biologics Evaluation and Research The Food […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0